Redesigning CI for Risk, Pricing, and Sustainability in APAC
Advances in detection, treatment, and survivorship are changing what it means to be critically ill. As diagnoses rise and treatment pathways evolve, insurers face a fundamental challenge: ensuring CI products remain affordable, relevant, and sustainable over time.
In this article, RGA’s Wilfred Tung and Ryan Hultzer explore how actuaries can help redesign CI products to better align benefits with financial need while supporting long-term portfolio sustainability.




